Department of General, Minimally Invasive and Endocrine Surgery, Wroclaw Medical University, 50-556 Wroclaw, Borowska Street 213, Wroclaw, Poland.
Department of Nervous System Diseases, Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland.
BMC Cancer. 2020 Nov 30;20(1):1166. doi: 10.1186/s12885-020-07636-0.
Papillary thyroid cancer (PTC) is unique among cancers in that patient age is a consideration in staging. One of the most important modifications in the 8th Edition of the American Joint Committee on Cancer (AJCC) classification is to increase the age cut off for risk stratification in PTC from 45 to 55 years. However, whether this cut off is useful in clinical practice remains controversial. In the present study, we assessed how well this new age threshold stratifies patients with aggressive PTC.
We retrospectively analyzed the clinicopathological features and overall survival rate of patients with PTC admitted to and surgically treated at a single surgical center. The study protocol was divided into two series. In each series all patients (n = 523) were divided in 2 groups according to age cut off. In the first series (cut off 45) patients < 45 (n = 193) vs. ≥45 (n = 330) were compared, and in the second series (cut off 55) patients < 55 (n = 306) vs. ≥55 (n = 217) were compared.
The rate of the prevalence of locally advanced disease (pT3 and pT4) was significantly higher in the patients above 55 years old than in those below 55 years old (p = 0.013). No significant differences were found for this parameter in series with cut off point 45 years old. A significantly higher risk of locally advanced disease T3 + T4 (OR = 4.87) and presence of LNM (N1) (OR = 3.78) was observed in ≥45 years old group (p = 0.021 and p < 0.0001, respectively). More expressive results were found for the patients ≥55 years old group, where the risk of locally advanced disease (T3 + T4) was higher (OR = 5.21) and LNM presence was OR = 4.76 (p < 0.001 and p < 0.0001, respectively). None of the patients below 55 years old showed distant metastasis, but 19 patients above 55 years old showed M1 (p < 0.0001). In older patients group (≥55 years old) we observed deaths related thyroid cancer in 11 individuals.
The age cut off of 55 years old for risk stratification proposed by the 8th Edition of AJCC effectively stratifies PTC patients with a poor prognosis, indicating it is likely to be useful in clinical practice.
甲状腺乳头状癌(PTC)在癌症中是独特的,因为患者年龄是分期的一个考虑因素。美国癌症联合委员会(AJCC)第 8 版分类中最重要的修改之一是将 PTC 的风险分层年龄截止值从 45 岁提高到 55 岁。然而,这个截止值在临床实践中是否有用仍然存在争议。在本研究中,我们评估了这个新的年龄阈值在具有侵袭性 PTC 的患者中的分层效果如何。
我们回顾性分析了在一个单一外科中心接受和接受手术治疗的 PTC 患者的临床病理特征和总生存率。研究方案分为两个系列。在每个系列中,所有患者(n=523)均根据年龄截止值分为两组。在第一系列(截止值 45 岁)中,<45 岁(n=193)与≥45 岁(n=330)相比,在第二系列(截止值 55 岁)中,<55 岁(n=306)与≥55 岁(n=217)相比。
55 岁以上患者局部晚期疾病(pT3 和 pT4)的患病率明显高于 55 岁以下患者(p=0.013)。在年龄截止值为 45 岁的系列中,没有发现这个参数有显著差异。≥45 岁组观察到局部晚期疾病 T3+T4(OR=4.87)和存在 LNM(N1)(OR=3.78)的风险显著升高(p=0.021 和 p<0.0001)。≥55 岁组的结果更为显著,其中局部晚期疾病(T3+T4)的风险更高(OR=5.21),LNM 的存在为 OR=4.76(p<0.001 和 p<0.0001)。没有一个 55 岁以下的患者出现远处转移,但 19 个 55 岁以上的患者出现了 M1(p<0.0001)。在≥55 岁的老年患者组中,我们观察到 11 例与甲状腺癌相关的死亡。
AJCC 第 8 版提出的 55 岁年龄截止值可有效分层预后不良的 PTC 患者,表明其可能在临床实践中有用。